Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Traws Pharma (TRAW) Other Accumulated Expenses (2016 - 2019)

Historic Other Accumulated Expenses for Traws Pharma (TRAW) over the last 8 years, with Q1 2019 value amounting to $14000.0.

  • Traws Pharma's Other Accumulated Expenses changed N/A to $14000.0 in Q1 2019 from the same period last year, while for Mar 2019 it was $14000.0, marking a year-over-year change of. This contributed to the annual value of $13000.0 for FY2018, which is N/A changed from last year.
  • As of Q1 2019, Traws Pharma's Other Accumulated Expenses stood at $14000.0.
  • In the past 5 years, Traws Pharma's Other Accumulated Expenses registered a high of $243000.0 during Q3 2016, and its lowest value of $6000.0 during Q4 2015.
  • Moreover, its 5-year median value for Other Accumulated Expenses was $88000.0 (2017), whereas its average is $102428.6.
  • In the last 5 years, Traws Pharma's Other Accumulated Expenses plummeted by 7391.3% in 2015 and then soared by 320000.0% in 2016.
  • Over the past 5 years, Traws Pharma's Other Accumulated Expenses (Quarter) stood at $6000.0 in 2015, then surged by 3200.0% to $198000.0 in 2016, then tumbled by 55.56% to $88000.0 in 2017, then plummeted by 85.23% to $13000.0 in 2018, then rose by 7.69% to $14000.0 in 2019.
  • Its Other Accumulated Expenses stands at $14000.0 for Q1 2019, versus $13000.0 for Q4 2018 and $88000.0 for Q1 2017.